What is the Ownership and Shareholding Structure of Snig Pharma?
In 2022, Snig Pharma had a promoter holding of 23.51% and a public holding of 76.49%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.










Company Details
+91-XXXXXXXXXX